FBN2 and bladder transitional cell carcinoma: Except for methotrexate, the chemotherapy drugs commonly used for BLCA, including cisplatin, docetaxel, doxorubicin, gemcitabine, and vinblastine, were all found to have statistically significant differences in drug susceptibility between the high and low FBN2 expression groups(Figure 6 a–f).